Protein Derivatives and Yeast Extract Group

These substances were identified for action under the Chemicals Management Plan (CMP). The screening assessment focuses on 4 substances referred to collectively as the Protein Derivatives and Yeast Extract Group.

Summary of publications
Substance group CAS RN Common name DSL name Draft screening assessment Proposed conclusion on section 64 criteria Follow-up activities
Protein Derivatives and Yeast Extract Group 8013-01-2Table 1 footnote a Yeast extract Yeast, ext. HTML Does not meet None planned at this time
9015-54-7Table 1 footnote a,Table 1 footnote b n/a Protein hydrolyzates
92113-31-0Table 1 footnote a,Table 1 footnote b Collagen hydrolyzates Collagens, hydrolyzates
111174-63-1Table 1 footnote a Isostearoyl hydrolyzed collagen Protein hydrolyzates, leather, reaction products with isostearoyl chloride
Timelines
Date Activity
February 2022 Anticipated publication of the final screening assessment.
February 6, 2021 Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 6.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: